Strife A - Search Results

1

Duration of the preclinical phase of chronic myelogenous leukemia: a case report.

Berman E, Strife A, Wisniewski D, Desai S, Gulati S, Jhanwar S, Clarkson BD. Berman E, et al. Among authors: strife a. Blood. 1991 Dec 1;78(11):2969-72. Blood. 1991. PMID: 1954384 Free article.

2

Constitutive expression of p53 protein in enriched normal human marrow blast cell populations.

Rivas CI, Wisniewski D, Strife A, Perez A, Lambek C, Bruno S, Darzynkiewicz Z, Clarkson B. Rivas CI, et al. Among authors: strife a. Blood. 1992 Apr 15;79(8):1982-6. Blood. 1992. PMID: 1562724 Free article.

3

Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction.

Wisniewski D, Strife A, Clarkson B. Wisniewski D, et al. Among authors: strife a. Leuk Res. 1991;15(9):867-74. doi: 10.1016/0145-2126(91)90471-5. Leuk Res. 1991. PMID: 1921462

4

Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.

Shimazaki C, Wisniewski D, Scheinberg DA, Atzpodien J, Strife A, Gulati S, Fried J, Wisniewolski R, Wang CY, Clarkson BD. Shimazaki C, et al. Among authors: strife a. Blood. 1988 Oct;72(4):1248-54. Blood. 1988. PMID: 3167207 Free article.

5

Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?

Strife A, Clarkson B. Strife A, et al. Semin Hematol. 1988 Jan;25(1):1-19. Semin Hematol. 1988. PMID: 3279512 Review. No abstract available.

6

Discordant maturation as the primary biological defect in chronic myelogenous leukemia.

Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD. Strife A, et al. Cancer Res. 1988 Feb 15;48(4):1035-41. Cancer Res. 1988. PMID: 3422181

7

Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.

Strife A, Perez A, Lambek C, Wisniewski D, Bruno S, Darzynkiewicz Z, Clarkson B. Strife A, et al. Cancer Res. 1993 Jan 15;53(2):401-9. Cancer Res. 1993. PMID: 7678076

8

Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML).

Clarkson B, Strife A, Perez A, Lambek C, Wisniewski D. Clarkson B, et al. Among authors: strife a. Leuk Lymphoma. 1993;11 Suppl 2:81-100. doi: 10.3109/10428199309064267. Leuk Lymphoma. 1993. PMID: 8124237

9

A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.

Wisniewski D, Strife A, Wojciechowicz D, Lambek C, Clarkson B. Wisniewski D, et al. Among authors: strife a. Leukemia. 1994 Apr;8(4):688-93. Leukemia. 1994. PMID: 8152267

10

Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.

Clarkson B, Strife A. Clarkson B, et al. Among authors: strife a. Leukemia. 1993 Nov;7(11):1683-721. Leukemia. 1993. PMID: 8231240 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters